1. Home
  2. News

News

A publication by scientists of the Anticancer Fund

Use of non-cancer drugs and survival among patients with pancreatic adenocarcinoma: a nationwide registry-based study in Norway

Nathalie C Støer, Gauthier Bouche, Pan Pantziarka, Erica K Sloan, Bettina K Andreassen, Edoardo Botteri. Use of non-cancer drugs and survival among patients with pancreatic adenocarcinoma: a nationwide registry-based study in Norway. Acta Oncol., 2021 Aug 2;1-8. doi: 10.1080/0284186X.2021.1953136
WHO - Repurposing medicines is the underrated champion of sustainable innovation in oncology - Anticancer Fund (with frame).jpg.png

WHO endorses drug repurposing strategy of the Anticancer Fund

First patient for EORTC-trial in oligometastatic rare cancers 

A publication by scientists of the Anticancer Fund

Trends in International Cancer Research Investment 2006-2018

Rachel Abudu, BS, MPH; Gauthier Bouche, MPH, MD; Karima Bourougaa, PhD; Lynne Davies, PhD; Kalina Duncan, BS, MPH; Carla Estaquio, PhD; Anna Diaz Font, PhD; Marc S. Hurlbert, PhD; Paul Jackson, PhD; Linda Kroeskop-Bossenbroek, PhD; Ian Lewis, PhD; Giota Mitrou, PhD; Abdul Mutabbir, BSc; Christopher A. Pettigrew, PhD; Lynn Turner, PhD; Annemarie Weerman, PhD; and Kari Wojtanik, PhD. Trends in International Cancer Research Investment 2006-2018. JCO Global Oncology, 2021 Apr;7:602-610. doi: 10.1200/GO.20.00591

Honorary association for Gauthier Bouche with University College London

Second step in trial for children with solid cancers